Highlights and Quick Summary
- EPS (Basic, from Discontinued Ops) for the quarter ending September 29, 2018 was 0.0
- Annual EPS (Basic, from Discontinued Ops) for 2018 was 1.04 (a 148471.43% increase from previous year)
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.
Historical EPS (Basic, from Discontinued Ops) of Progyny, Inc.Most recent EPS (Basic, from Discontinued Ops)of PGNY including historical data for past 10 years.
Interactive Chart of EPS (Basic, from Discontinued Ops) of Progyny, Inc.
Progyny, Inc. EPS (Basic, from Discontinued Ops) for the past 10 Years (both Annual and Quarterly)
Business Profile of Progyny, Inc.
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.